The  logo

EU

  1. Pregabalin an effective alternative to dopaminergics for restless leg syndrome

    17 Feb 14 | 16.13 | EU International

    Pregabalin is more effective than standard treatment with the dopamine agonist pramipexole in patients with restless leg syndrome and may offer additional benefits...

    more >

  2. European Medicines Agency acknowledges limitations of paediatric licensing rules

    12 Feb 14 | 15.06 | EU

    The European Medicines Agency has acknowledged that there is a lack of development of medicines for paediatric cancers...

    more >

  3. The challenges we share with some EU countries: what can we learn?

    11 Feb 14 | 9.56 | England EU

    It is easy to say pharmacy in the UK is all doom and gloom. But are we really doing that badly? John Chave compares us with some European countries

    more >

  4. Dimethyl fumarate becomes second oral agent launched for MS this year

    7 Feb 14 | 14.53 | EU

    Patients with relapsing-remitting multiple sclerosis now have a further oral treatment option available, dimethyl fumarate...

    more >

  5. Nab-paclitaxel licensed for advanced pancreatic cancer

    6 Feb 14 | 16.20 | England EU Scotland Wales

    Patients with metastatic pancreatic cancer can now be treated with nanoparticle albumin-bound (nab)-paclitaxel...

    more >

  6. Information on animal-derived ingredients in medicines difficult to obtain

    5 Feb 14 | 16.21 | England EU Northern Ireland Scotland Wales

    Vegetarians and other patients with dietary restrictions may be unaware that commonly prescribed medicines contain animal products...

    more >

  7. Non-interferon hepatitis C treatment launched, but NHS funding unclear

    31 Jan 14 | 15.34 | England EU Scotland Wales

    Patients with chronic hepatitis C have a new treatment option, sofosbuvir, which offers hope of a cure...

    more >

  8. EMA reviews efficacy of emergency contraceptives in women with high bodyweight

    28 Jan 14 | 16.07 | EU

    The European Medicines Agency has launched a review into whether the efficacy of emergency contraceptives is reduced in women with high bodyweight...

    more >

  9. NICE gives green light to teriflunomide, a new oral MS treatment

    22 Jan 14 | 15.24 | England EU Scotland Wales

    Multiple sclerosis patients now have access to a new oral treatment option after teriflunomide was recommended by NICE... more >

  10. McKesson takeover of Celesio called off

    17 Jan 14 | 15.55 | England EU International Scotland Wales

    McKesson, a pharmaceutical distributor in the US, has failed in its bid to takeover Celesio, parent company of Lloydspharmacy and AAH.

    more >